BAY-76-7171

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBAY-76-7171
Drug Alias Nameantidiabetic (CuraGen/Bayer)CT-052BAY-76-7171
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuraGen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuraGen CorpBayer AG
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A